Literature DB >> 17976314

Diverse functions of VDUP1 in cell proliferation, differentiation, and diseases.

Sang Yong Kim1, Hyun-Woo Suh, Jin Woong Chung, Suk-Ran Yoon, Inpyo Choi.   

Abstract

Vitamin D3 up-regulated protein 1 (VDUP1) is a multifunctional protein involved in maintaining cellular homeostasis. VDUP1 is induced by a variety of stresses. Inversely, VDUP1 is often reduced in various tumor tissues and cell lines. Over-expression of VDUP1 inhibits cell proliferation through cell cycle arrest. VDUP1 interacts with thioredoxin (Trx) and negatively regulates the expression and antioxidant function of Trx which is involved in redox regulation. VDUP1-/- mice are more susceptible to carcinogenesis than wild-type mice and are defective in establishing immune system including the development and function of natural killer cells. Furthermore, VDUP1-/- mice show impaired Kreb cycle-mediated fatty acid utilization. In this review, we have discussed the multifunctional roles of VDUP1 in diverse cellular responses, in particular its relation to proliferation, apoptosis, differentiation, and diseases such as cancer and stress-related diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17976314

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  47 in total

1.  Verapamil Inhibits Ser202/Thr205 Phosphorylation of Tau by Blocking TXNIP/ROS/p38 MAPK Pathway.

Authors:  Mariarosa Anna Beatrice Melone; Clemente Dato; Simona Paladino; Cinzia Coppola; Claudia Trebini; Maria Teresa Giordana; Lorena Perrone
Journal:  Pharm Res       Date:  2018-02-05       Impact factor: 4.200

2.  Effects of vitamin D3 stimulation of thioredoxin-interacting protein in hepatocellular carcinoma.

Authors:  James P Hamilton; James J Potter; Lahari Koganti; Stephen J Meltzer; Esteban Mezey
Journal:  Hepatol Res       Date:  2014-03-25       Impact factor: 4.288

Review 3.  Coordination of nutrient availability and utilization by MAX- and MLX-centered transcription networks.

Authors:  John M O'Shea; Donald E Ayer
Journal:  Cold Spring Harb Perspect Med       Date:  2013-09-01       Impact factor: 6.915

4.  Tissue thioredoxin-interacting protein expression predicted recurrence in patients with meningiomas.

Authors:  Zheng Cai; Chenran Zhang; Yongxiang Zou; Chengyin Lu; Hongkang Hu; Jun Qian; Lei Jiang; Guohan Hu
Journal:  Int J Clin Oncol       Date:  2017-02-27       Impact factor: 3.402

5.  Thioredoxin-interacting protein links oxidative stress to inflammasome activation.

Authors:  Rongbin Zhou; Aubry Tardivel; Bernard Thorens; Inpyo Choi; Jürg Tschopp
Journal:  Nat Immunol       Date:  2009-12-20       Impact factor: 25.606

6.  Myc, mondo, and metabolism.

Authors:  Elizabeth J Sloan; Donald E Ayer
Journal:  Genes Cancer       Date:  2010-06

7.  Astragaloside IV ameliorates necrotizing enterocolitis by attenuating oxidative stress and suppressing inflammation via the vitamin D3-upregulated protein 1/NF-κB signaling pathway.

Authors:  Zhiyong Cai; Jindi Liu; Hongliang Bian; Jinlan Cai
Journal:  Exp Ther Med       Date:  2016-08-30       Impact factor: 2.447

8.  Tandem ChoRE and CCAAT motifs and associated factors regulate Txnip expression in response to glucose or adenosine-containing molecules.

Authors:  Fa-Xing Yu; Yan Luo
Journal:  PLoS One       Date:  2009-12-22       Impact factor: 3.240

9.  Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer.

Authors:  Cristina Cadenas; Dennis Franckenstein; Marcus Schmidt; Mathias Gehrmann; Matthias Hermes; Bettina Geppert; Wiebke Schormann; Lindsey J Maccoux; Markus Schug; Anika Schumann; Christian Wilhelm; Evgenia Freis; Katja Ickstadt; Jörg Rahnenführer; Jörg I Baumbach; Albert Sickmann; Jan G Hengstler
Journal:  Breast Cancer Res       Date:  2010-06-28       Impact factor: 6.466

10.  Raising gestational choline intake alters gene expression in DMBA-evoked mammary tumors and prolongs survival.

Authors:  Vesela P Kovacheva; Jessica M Davison; Tiffany J Mellott; Adrianne E Rogers; Shi Yang; Michael J O'Brien; Jan Krzysztof Blusztajn
Journal:  FASEB J       Date:  2008-12-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.